Efficient, multi-hundred-gram scale access to E3 ubiquitin ligase ligands for degrader development von Cooper, Mark S, Norley, Mark C, Armitage, Simon, Cresser-Brown, Joel O, Edmonds, Anthony K, Goggins, Sean, Hopewell, Jonathan P, Karadogan, Burhan, Knights, Kevin A, Nash, Toby J, Oakes, Catherine S, O'Neill, William J, Pridmore, Simon J, Maple, Hannah J, Marsh, Graham P

Volltext

Synthesis of racemic brevioxime and related analogues von Karadogan, Burhan, Parsons, Philip J

Volltext

PROTEOLYSIS-TARGETING CHIMERAS AGAINST THE PAPAIN-LIKE PROTEASE OF SARS-COV-2 von KARADOGAN, Burhan, BRÖNSTRUP, Mark, SIEMON, Thomas, MAPLE, Hannah, ROX, Katharina, HILGENFELD, Rolf, MOLONEY, Alex, MARSH, Graham

Volltext bestellen

PROTACS USEFUL AGAINST THE MAIN PROTEASE SARS-COV-2 von KARADOGAN, Burhan, BRÖNSTRUP, Mark, SIEMON, Thomas, MAPLE, Hannah, ROX, Katharina, HILGENFELD, Rolf, MOLONEY, Alex, MARSH, Graham

Volltext bestellen

A novel synthesis oftrans-enynes from substituted tetrahydropyrans von Karadogan, Burhan, Edwards, Neil, Parsons, Philip J.

Volltext

A Rapid Synthesis of Racemic Brevioxime von Parsons, Philip J., Karadogan, Burhan, Macritchie, Jacqueline A.

Volltext

A novel synthesis of trans-enynes from substituted tetrahydropyrans von Karadogan, Burhan, Edwards, Neil, Parsons, Philip J.

Volltext

ChemInform Abstract: A Novel Synthesis of trans-Enynes from Substituted Tetrahydropyrans von Karadogan, Burhan, Edwards, Neil, Parsons, Philip J.

Volltext

Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience von Bekoz, Huseyin, Ozbalak, Murat, Karadurmus, Nuri, Paydas, Semra, Turker, Alev, Toptas, Tayfur, Tuglular, Tülin Firatli, Altuntas, Fevzi, Cakar, Merih Kizil, Sonmez, Mehmet, Gulbas, Zafer, Demir, Nazlı, Kaynar, Leylagul, Yildirim, Rahsan, Karadogan, Ihsan, Arat, Mutlu, Kapucu, Irem, Aslan, Nevin Alayvaz, Ozkocaman, Vildan, Turgut, Mehmet, Yuksel, Meltem Kurt, Ozcan, Muhit, Hacioglu, Sibel Kabukcu, Barista, Ibrahim, Demirkaya, Metin, Saydam, Guray, Toprak, Selami K., Yilmaz, Mehmet, Demirkol, Onur, Ferhanoglu, Burhan

Volltext

Long-term results of brentuximab vedotin in relapsed and refractory Hodgkin lymphoma: multi-center real-life experience von Özbalak, Murat, Salihoğlu, Ayşe, Soysal, Teoman, Karadoğan, İhsan, Paydaş, Semra, Özdemir, Evren, Yıldız, Birol, Karadurmuş, Nuri, Kaynar, Leylagül, Yagci, Münci, Özkocaman, Vildan, Topçuoğlu, Pervin, Özcan, Muhit, Birtaş, Elif, Göker, Hakan, Ferhanoglu, Burhan

Volltext

Long-Term Results of Brentuximab Vedotin in Relapsed and Refractory Hodgkin Lymphoma: Multi-Center Real-Life Experience von Ferhanoglu, A. Burhan, Özbalak, Murat, Salihoglu, Ayse, Soysal, Teoman, Karadoğan, ihsan, Paydas, Semra, Ozdemir, Evren, Yıldız, Birol, Karadurmuş, Nuri, Kaynar, Leylagül, Yeğin, Zeynep Arzu, Pınar Özbalak, Ezgi, Sucak, Gülsan, Ozkocaman, Vildan, Topçuoğlu, Pervin, Ozcan, Muhit, Birtas, Elif, Goker, Hakan

Volltext